Incyte (INCY) News

2 days Incyte Pauses Enrollment in Chronic Spontaneous Urticaria StudyZacks X

2 days Incyte Collapses. Why Its $750 Million Escient Acquisition Now Looks Shattered.Investor's Business Daily X

2 days After-hours movers: Super Micro Computer, Bakkt Holdings, Incyte, and moreInvesting.com X

3 days Is Incyt Corporation (INCY) the Best Immunotherapy Stock to Buy Now?Insider Monkey X

2 weeks BMRN vs. INCY: Which Stock Is the Better Value Option?Zacks X

3 weeks Incyte (NASDAQ:INCY) Announces Quarterly Earnings ResultsMarketBeat X

3 weeks Earnings call: Incyte reports robust growth and pipeline progressInvesting.com X

3 weeks Incyte (NASDAQ:INCY) Raised to “Buy” at Bank of AmericaMarketBeat X

3 weeks Incyte Breaks Out To 17-Month High As Jakafi Demand SurgesInvestor's Business Daily X

3 weeks INCY Q3 Earnings Miss Estimates, Revenues Beat on Higher Product SalesZacks X

3 weeks Here’s What Key Metrics Tell Us About Incyte (INCY) Q3 EarningsZacks X

3 weeks Incyte Co. (NASDAQ:INCY) Shares Sold by Mediolanum International Funds LtdMarketBeat X

4 weeks Dumont & Blake Investment Advisors LLC Sells 25,529 Shares of Incyte Co. (NASDAQ:INCY)MarketBeat X

4 weeks Incyte Gears Up to Report Q3 Earnings: Here’s What You Should KnowZacks X

1 month Incyte (INCY) Scheduled to Post Quarterly Earnings on TuesdayMarketBeat X